GOBBI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 275
NA - Nord America 13
Totale 288
Nazione #
FR - Francia 257
US - Stati Uniti d'America 13
IT - Italia 11
IE - Irlanda 4
BG - Bulgaria 2
GB - Regno Unito 1
Totale 288
Città #
Forlì 9
Columbus 5
Dublin 4
Sofia 2
Ashburn 1
Atlanta 1
Bologna 1
Crugers 1
Dallas 1
New York 1
Totale 26
Nome #
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling, file 37c13c19-d752-4639-b487-4d1e99e8e82f 253
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer, file e1dcb339-090f-7715-e053-1705fe0a6cc9 16
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma, file e1dcb339-45a3-7715-e053-1705fe0a6cc9 14
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling, file 6a558482-34f2-4854-bc14-a80a4c06c3d1 2
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling, file a9414809-980f-4693-987e-dfe6de0cf10c 1
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling, file dba9f7c2-9598-4c2b-b52c-dbd2ee58c047 1
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells, file e1dcb334-6381-7715-e053-1705fe0a6cc9 1
Totale 288
Categoria #
all - tutte 542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 1 1 0 0 0 0
2022/202313 0 0 0 1 1 5 0 1 4 1 0 0
2023/2024273 0 1 0 2 0 4 0 2 2 0 262 0
Totale 288